Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study. [electronic resource]
- Journal of affective disorders Aug 2015
- 44-9 p. digital
Publication Type: Journal Article
1573-2517
10.1016/j.jad.2015.04.027 doi
Adult Anastrozole Androstadienes--therapeutic use Antineoplastic Agents--therapeutic use Aromatase Inhibitors--therapeutic use Breast Neoplasms--epidemiology Chemotherapy, Adjuvant Depressive Disorder--epidemiology Female Follow-Up Studies Humans Kaplan-Meier Estimate Letrozole Middle Aged Nitriles--therapeutic use Population Surveillance--methods Proportional Hazards Models Retrospective Studies Risk Taiwan--epidemiology Tamoxifen--therapeutic use Trastuzumab--therapeutic use Triazoles--therapeutic use